Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
INTS
#3863
Intensity Therapeutics, Inc. Common stock
7.6
6
+4.64%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+4.64%
Changement Mensuel
+1915.79%
Evolution sur 6 mois
+2541.38%
Changement Annuel
+234.50%
Clôture Précédente
7.3
2
Open
7.6
6
Bid
Ask
Low
7.6
6
High
7.6
6
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
INTS
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
548.38 K
607.24 K
—
Valuation ratios
Enterprise value
-3.8 M
-1.52 M
-9.12 M
Price to earnings ratio
-0.25
-0.06
-0.17
Price to sales ratio
1.32
—
—
Price to cash flow ratio
0.41
0.06
0.18
Price to book ratio
0.23
0.34
0.47
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
0.61
3.41
2.6
Return on equity %
0.8
5.59
12.51
Return on invested capital %
1 797.73
4 021.82
—
Gross margin %
100
—
—
Operating margin %
367.77
—
—
EBITDA margin %
—
—
—
Net margin %
464.19
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
3.91
1.92
7.54
Inventory turnover
—
—
—
Asset turnover
0.13
0
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
20.91
27.36
12.71
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
42.94
4.67
13.2
Net current asset value per share
44.87
6.05
17.55
Tangible book value per share
38.19
5.25
12.88
Working capital per share
33.38
2.89
5.87
Book value per share
38.19
5.25
12.88
Nouvelles
Qu'est-ce qui se passe avec les actions d'Intensity Therapeutics vendredi ? | Benzinga France
Intensity Therapeutics annonce un regroupement d’actions à raison de 1 pour 25
Intensity Therapeutics announces 1-for-25 reverse stock split
What's Going On With Intensity Therapeutics Stock Friday? - Intensity Therapeutics (NASDAQ:INTS)
Intensity Therapeutics présente ses priorités pour 2026 après validation clinique
Intensity therapeutics outlines 2026 priorities after clinical validation
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Le titre d’Intensity Therapeutics grimpe après l’obtention d’un délai du Nasdaq
Intensity Therapeutics stock rises after securing Nasdaq listing extension
Intensity Therapeutics obtient une prolongation de 180 jours pour se conformer aux règles du Nasdaq
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule
Intensity Therapeutics étend son programme d’offre sur le marché à 30 millions $